Tirzepatide is a dual-action medication that activates both GIP and GLP-1 receptors, offering a two-pronged approach to appetite control and blood sugar regulation Semaglutide works primarily through GLP-1 receptor activation, which also effectively reduces appetite and improves blood sugar control Why Choose Prima Medicine
Ye M, Sun J, Chen Y, Ren Q, Li Z, Zhao Y, et al
PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 38 H 49 N 9 O 5 Weight: 711.86 g/mol CAS: 170851-70-4 Structure: Aib-His-D-2-Nal-D-Phe-Lys PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Readily dissolves in water Selectivity: High receptor selectivity Storage: Keep refrigerated 3646 F (28 C)
This requires a physicians request to the manufacturer and FDA authorization
The hormones in this class of drugs signal the brain to suppress your appetite, so you eat less and feel full longer
I recently posted a video about issues I had with MIDI Health, and one of their C-suite folks reached out to suggest we should talk, because our values are probably closer aligned than we think